These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34211838)

  • 21. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
    Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
    Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer.
    Silva CMS; Barros-Filho MC; Wong DVT; Mello JBH; Nobre LMS; Wanderley CWS; Lucetti LT; Muniz HA; Paiva IKD; Kuasne H; Ferreira DPP; Cunha MPSS; Hirth CG; Silva PGB; Sant'Ana RO; Souza MHLP; Quetz JS; Rogatto SR; Lima-Junior RCP
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs.
    Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
    Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
    Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
    Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
    Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of microRNAs in skeletal muscle associated with lung cancer cachexia.
    van de Worp WRPH; Schols AMWJ; Dingemans AC; Op den Kamp CMH; Degens JHRJ; Kelders MCJM; Coort S; Woodruff HC; Kratassiouk G; Harel-Bellan A; Theys J; van Helvoort A; Langen RCJ
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):452-463. PubMed ID: 31828982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.
    Bowden M; Zhou CW; Zhang S; Brais L; Rossi A; Naudin L; Thiagalingam A; Sicinska E; Kulke MH
    Oncotarget; 2017 Aug; 8(33):54331-54344. PubMed ID: 28903345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum miRNA Signature in Rheumatoid Arthritis and "At-Risk Individuals".
    Cunningham CC; Wade S; Floudas A; Orr C; McGarry T; Wade S; Cregan S; Fearon U; Veale DJ
    Front Immunol; 2021; 12():633201. PubMed ID: 33746971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
    Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-miRNA Signature to Identify Asbestos-Related Lung Malignancies.
    Santarelli L; Gaetani S; Monaco F; Bracci M; Valentino M; Amati M; Rubini C; Sabbatini A; Pasquini E; Zanotta N; Comar M; Neuzil J; Tomasetti M; Bovenzi M
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):119-126. PubMed ID: 30257964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of exhaled breath condensate microRNAs to identify and endotype asthma in children.
    Mendes FC; Paciência I; Ferreira AC; Martins C; Rufo JC; Silva D; Cunha P; Farraia M; Moreira P; Delgado L; Soares ML; Moreira A
    PLoS One; 2019; 14(11):e0224983. PubMed ID: 31703106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 39. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.